These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 19748432)

  • 21. Detection and quantification of cytomegalovirus in bone marrow transplant recipients by real time PCR and pp65 antigenemia.
    Gokahmetoglu S; Kaynar L; Altuntas F; Yildiz O; Cetin M; Kocyigit I
    Saudi Med J; 2008 Nov; 29(11):1673-5. PubMed ID: 18998025
    [No Abstract]   [Full Text] [Related]  

  • 22. Monitoring of human cytomegalovirus glycoprotein B genotypes using real-time quantitative PCR in immunocompromised Chinese patients.
    Fan J; Zhang X; Chen XM; Gao HN; Yang MF; Zhao H; Hu JH; Ma WH
    J Virol Methods; 2009 Sep; 160(1-2):74-7. PubMed ID: 19406161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantification of human cytomegalovirus DNA in bone marrow transplant recipients by real-time PCR.
    Griscelli F; Barrois M; Chauvin S; Lastere S; Bellet D; Bourhis JH
    J Clin Microbiol; 2001 Dec; 39(12):4362-9. PubMed ID: 11724846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and application of a novel multiplex polymerase chain reaction for semi-quantitation of human Cytomegalovirus in clinical specimens.
    Madhavan HN; Sowmya P; Therese KL; Malathi J
    J Virol Methods; 2007 May; 141(2):166-72. PubMed ID: 17222918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of an automated extraction system in combination with Affigene CMV Trender for CMV DNA quantitative determination: comparison with nested PCR and pp65 antigen test.
    Abbate I; Finnstrom N; Zaniratti S; Solmone MC; Selvaggini S; Bennici E; Neri S; Brega C; Paterno M; Capobianchi MR
    J Virol Methods; 2008 Jul; 151(1):61-5. PubMed ID: 18462815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early diagnosis and monitoring of active HCMV infection in children with systemic lupus erythematosus.
    Zhang C; Shen K; Jiang Z; He X
    Chin Med J (Engl); 2001 Dec; 114(12):1309-12. PubMed ID: 11793860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison between RFLP-PCR and antigenemia for pp65 antigen for diagnosis of cytomegalovirus disease after kidney transplantation.
    Schröeder R; Michelon T; Fagundes I; Bortolotto A; Petry M; Lammerhirt E; Santos L; Cantarelli V; Keitel E; Garcia V; Neumann J
    Transplant Proc; 2004 May; 36(4):891-3. PubMed ID: 15194306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between pp65 antigenemia levels and real-time quantitative DNA PCR for Human Cytomegalovirus (HCMV) management in immunocompromised patients.
    Cariani E; Pollara CP; Valloncini B; Perandin F; Bonfanti C; Manca N
    BMC Infect Dis; 2007 Nov; 7():138. PubMed ID: 18036216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of a new Light Diagnostics and the CMV Brite to an in-house developed human cytomegalovirus antigenemia assay.
    Percivalle E; Genini E; Chiesa A; Gerna G
    J Clin Virol; 2008 Sep; 43(1):13-7. PubMed ID: 18468948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a quantitative-competitive PCR for quantification of human cytomegalovirus load and comparison with antigenaemia, viraemia and pp67 RNA detection by nucleic acid sequence-based amplification.
    Bergallo M; Costa C; Tarallo S; Daniele R; Merlino C; Segoloni GP; Negro Ponzi A; Cavallo R
    Panminerva Med; 2006 Jun; 48(2):119-27. PubMed ID: 16953149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In situ RT-PCR can distinguish between productive and latent cytomegalovirus infection in the blood cells of bone marrow transplant recipients.
    Zawilinska B; Bulek K; Kopec J; Daszkiewicz E; Rojek-Zakrzewska D; Kosz-Vnenchak M
    Acta Virol; 2006; 50(1):67-70. PubMed ID: 16599188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prognosis value of the pp65 antigenemia and semi-quantitative PCR in the detection of the CMV reactivation in bone marrow grafted patients].
    Ksouri H; Lakhal A; Ben Amor R; Torjman L; Achour W; Ben Othmen T; Ladeb S; Abdelkefi A; Slim A; Abdeladhim A; Ben Hassen A
    Bull Soc Pathol Exot; 2006 Jul; 99(3):155-9. PubMed ID: 16983816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective study comparing cytomegalovirus antigenemia, DNAemia and RNAemia tests in guiding pre-emptive therapy in thoracic organ transplant recipients.
    Lehto JT; Lemström K; Halme M; Lappalainen M; Lommi J; Sipponen J; Harjula A; Tukiainen P; Koskinen PK
    Transpl Int; 2005 Dec; 18(12):1318-27. PubMed ID: 16297050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "pp65 antigenemia and real time polymerase chain reaction (PCR) based-study to determine the prevalence of human cytomegalovirus (HCMV) in kidney donors and recipients with follow-up studies".
    Madhavan HN; Samson MY; Ishwarya M; Vijayakumar R; Jambulingam M
    Virol J; 2010 Nov; 7():322. PubMed ID: 21080922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of human cytomegalovirus in renal transplantation: comparison of four diagnostic methods: DNA in sera by polymerase chain reaction (PCR), DNA in leukocyte by PCR, pp65 leukocytic antigenemia, and viremia.
    Eckart P; Brouard J; Vabret A; Freymuth F; Guillot M; Ryckelynck JP; Hurault de Ligny B
    Transplant Proc; 1997 Aug; 29(5):2387-9. PubMed ID: 9270775
    [No Abstract]   [Full Text] [Related]  

  • 36. Quantitative real-time PCR compared with pp65 antigen detection for cytomegalovirus (CMV) in 1122 blood specimens from 77 patients after allogeneic stem cell transplantation: which test better predicts CMV disease development?
    Nitsche A; Oswald O; Steuer N; Schetelig J; Radonić A; Thulke S; Siegert W
    Clin Chem; 2003 Oct; 49(10):1683-5. PubMed ID: 14500600
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunohistochemically proven cytomegalovirus end-organ disease in solid organ transplant patients: clinical features and usefulness of conventional diagnostic tests.
    Fica A; Cervera C; Pérez N; Marcos MA; Ramírez J; Linares L; Soto G; Navasa M; Cofan F; Ricart MJ; Pérez-Villa F; Pumarola T; Moreno A
    Transpl Infect Dis; 2007 Sep; 9(3):203-10. PubMed ID: 17511827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multicentric evaluation of a new commercial cytomegalovirus real-time PCR quantitation assay.
    Gouarin S; Vabret A; Scieux C; Agbalika F; Cherot J; Mengelle C; Deback C; Petitjean J; Dina J; Freymuth F
    J Virol Methods; 2007 Dec; 146(1-2):147-54. PubMed ID: 17673304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of LightCycler-based PCR, COBAS amplicor CMV monitor, and pp65 antigenemia assays for quantitative measurement of cytomegalovirus viral load in peripheral blood specimens from patients after solid organ transplantation.
    Pang XL; Chui L; Fenton J; LeBlanc B; Preiksaitis JK
    J Clin Microbiol; 2003 Jul; 41(7):3167-74. PubMed ID: 12843059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Real-time fluorescent quantitative PCR assay for measuring cytomegalovirus DNA load in patients after haematopoietic stem cell transplantation.
    Fan J; Ma WH; Yang MF; Xue H; Gao HN; Li LJ
    Chin Med J (Engl); 2006 May; 119(10):871-4. PubMed ID: 16732992
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.